Parametric response mapping of dynamic CT for predicting intrahepatic recurrence of hepatocellular carcinoma after conventional transcatheter arterial chemoembolization

详细信息    查看全文

• 作者：Seung Joon Choi ; Jonghoon Kim ; Jongbum Seo ; Hyung Sik Kim&#8230
• 关键词：Hepatocellular carcinoma ; Algorithms ; Therapeutic chemoembolization ; Tomography ; X ; Ray computed ; Longitudinal studies
• 刊名：European Radiology
• 出版年：2016
• 出版时间：January 2016
• 年：2016
• 卷：26
• 期：1
• 页码：225-234
• 全文大小：2,753 KB
• 参考文献：1.Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74鈥?08CrossRef PubMed
  2.Parkin DM, Bray F, Ferlay J, Pisani P (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94:153鈥?56CrossRef PubMed
  3.Mazzaferro V, Regalia E, Doci R et al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693鈥?99CrossRef PubMed
  4.Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421鈥?30CrossRef PubMed
  5.Bruix J, Llovet JM (2002) Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 35:519鈥?24CrossRef PubMed
  6.Lai EC, Fan ST, Lo CM, Chu KM, Liu CL, Wong J (1995) Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg 221:291鈥?98PubMedCentral CrossRef PubMed
  7.Adachi E, Maeda T, Matsumata T et al (1995) Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology 108:768鈥?75CrossRef PubMed
  8.Livraghi T, Giorgio A, Marin G et al (1995) Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 197:101鈥?08CrossRef PubMed
  9.Bronowicki JP, Boudjema K, Chone L et al (1996) Comparison of resection, liver transplantation and transcatheter oily chemoembolization in the treatment of hepatocellular carcinoma. J Hepatol 24:293鈥?00CrossRef PubMed
  10.Choi JW, Park JY, Ahn SH et al (2009) Efficacy and safety of transarterial chemoembolization in recurrent hepatocellular carcinoma after curative surgical resection. Am J Clin Oncol 32:564鈥?69CrossRef PubMed
  11.Braga L, Guller U, Semelka RC (2005) Pre-, peri-, and posttreatment imaging of liver lesions. Radiol Clin N Am 43:915鈥?27, viii CrossRef PubMed
  12.Bolondi L, Gaiani S, Celli N et al (2005) Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 42:27鈥?4CrossRef PubMed
  13.Kim SH, Lee WJ, Lim HK, Lim JH (2007) Prediction of viable tumor in hepatocellular carcinoma treated with transcatheter arterial chemoembolization: usefulness of attenuation value measurement at quadruple-phase helical computed tomography. J Comput Assist Tomogr 31:198鈥?03CrossRef PubMed
  14.Hunt SJ, Yu W, Weintraub J, Prince MR, Kothary N (2009) Radiologic monitoring of hepatocellular carcinoma tumor viability after transhepatic arterial chemoembolization: estimating the accuracy of contrast-enhanced cross-sectional imaging with histopathologic correlation. J Vasc Interv Radiol 20:30鈥?8CrossRef PubMed
  15.Kim HC, Kim AY, Han JK et al (2002) Hepatic arterial and portal venous phase helical CT in patients treated with transcatheter arterial chemoembolization for hepatocellular carcinoma: added value of unenhanced images. Radiology 225:773鈥?80CrossRef PubMed
  16.Kim TK, Choi BI, Han JK, Chung JW, Park JH, Han MC (1998) Nontumorous arterioportal shunt mimicking hypervascular tumor in cirrhotic liver: two-phase spiral CT findings. Radiology 208:597鈥?03CrossRef PubMed
  17.Galban CJ, Chenevert TL, Meyer CR et al (2011) Prospective analysis of parametric response map-derived MRI biomarkers: identification of early and distinct glioma response patterns not predicted by standard radiographic assessment. Clin Cancer Res 17:4751鈥?760PubMedCentral CrossRef PubMed
  18.Galban CJ, Chenevert TL, Meyer CR et al (2009) The parametric response map is an imaging biomarker for early cancer treatment outcome. Nat Med 15:572鈥?76PubMedCentral CrossRef PubMed
  19.Hamstra DA, Chenevert TL, Moffat BA et al (2005) Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. Proc Natl Acad Sci U S A 102:16759鈥?6764PubMedCentral CrossRef PubMed
  20.Moffat BA, Chenevert TL, Lawrence TS et al (2005) Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci U S A 102:5524鈥?529PubMedCentral CrossRef PubMed
  21.Choi SJ, Kim J, Seo J, Kim HS, Lee JM, Park H (2014) Parametric response mapping of dynamic CT as an imaging biomarker to distinguish viability of hepatocellular carcinoma treated with transcatheter arterial chemoembolization. Abdom Imaging 39:518鈥?25CrossRef PubMed
  22.Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020鈥?022PubMedCentral CrossRef PubMed
  23.Jin YJ, Chung YH, Kim JA et al (2013) Predisposing factors of hepatocellular carcinoma recurrence following complete remission in response to transarterial chemoembolization. Dig Dis Sci 58:1758鈥?765CrossRef PubMed
  24.Ishimaru H, Nakashima K, Sakugawa T et al (2014) Local recurrence after chemoembolization of hepatocellular carcinoma: uptake of gadoxetic acid as a new prognostic factor. Am J Roentgenol 202:744鈥?51CrossRef
  25.Castellano L, Calandra M, Del Vecchio Blanco C, de Sio I (1997) Predictive factors of survival and intrahepatic recurrence of hepatocellular carcinoma in cirrhosis after percutaneous ethanol injection: analysis of 71 patients. J Hepatol 27:862鈥?70CrossRef PubMed
  26.Meyer CR, Boes JL, Kim B et al (1997) Demonstration of accuracy and clinical versatility of mutual information for automatic multimodality image fusion using affine and thin-plate spline warped geometric deformations. Med Image Anal 1:195鈥?06CrossRef PubMed
  27.Takayasu K, Arii S, Matsuo N et al (2000) Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma. Am J Roentgenol 175:699鈥?04CrossRef
  28.Bargellini I, Bozzi E, Campani D et al (2013) Modified RECIST to assess tumor response after transarterial chemoembolization of hepatocellular carcinoma: CT-pathologic correlation in 178 liver explants. Eur J Radiol 82:e212鈥揺218CrossRef PubMed
  29.Gnanadesikan R, Kettenring JR (1972) Robust estimates, residuals, and outlier detection with multi-response data. Biometrics 28:81鈥?24CrossRef
  30.Wobser H, Wiest R, Salzberger B, Wohlgemuth WA, Stroszczynski C, Jung EM (2014) Evaluation of treatment response after chemoembolisation (TACE) in hepatocellular carcinoma using real time image fusion of contrast-enhanced ultrasound (CEUS) and computed tomography (CT) - preliminary results. Clin Hemorheol Microcirc 57:191鈥?01PubMed
  31.Yu JS, Kim KW, Sung KB, Lee JT, Yoo HS (1997) Small arterial-portal venous shunts: a cause of pseudolesions at hepatic imaging. Radiology 203:737鈥?42CrossRef PubMed
  32.Park W, Chung YH, Kim JA et al (2013) Recurrences of hepatocellular carcinoma following complete remission by transarterial chemoembolization or radiofrequency therapy: focused on the recurrence patterns. Hepatol Res 43:1304鈥?312CrossRef PubMed
  33.Bargellini I, Sacco R, Bozzi E et al (2012) Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: a prospective cohort study. Eur J Radiol 81:1173鈥?178CrossRef PubMed
  34.Lee JK, Chung YH, Song BC et al (2002) Recurrences of hepatocellular carcinoma following initial remission by transcatheter arterial chemoembolization. J Gastroenterol Hepatol 17:52鈥?8CrossRef PubMed
  35.Okada S, Shimada K, Yamamoto J et al (1994) Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology 106:1618鈥?624PubMed
  36.Chapiro J, Duran R, Lin M et al (2015) Early survival prediction after intra-arterial therapies: a 3D quantitative MRI assessment of tumour response after TACE or radioembolization of colorectal cancer metastases to the liver. Eur Radiol. doi:10.鈥?007/鈥媠00330-015-3595-5 PubMedCentral
  37.Kloeckner R, Otto G, Biesterfeld S, Oberholzer K, Dueber C, Pitton MB (2010) MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma. Cardiovasc Intervent Radiol 33:532鈥?40CrossRef PubMed
  38.Kim HJ, Kim TK, Kim PN et al (2006) Assessment of the therapeutic response of hepatocellular carcinoma treated with transcatheter arterial chemoembolization: comparison of contrast-enhanced sonography and 3-phase computed tomography. J Ultrasound Med 25:477鈥?86PubMed
  
• 作者单位：Seung Joon Choi (1)
  Jonghoon Kim (2)
  Jongbum Seo (3)
  Hyung Sik Kim (1)
  Jong-min Lee (4)
  Hyunjin Park (5)
  
  1. Department of Radiology, Gachon University Gil Hospital, Incheon, Korea
  2. Department of Electronic Electrical and Computer Engineering, Sungkyunkwan University, Suwon, 440-746, Korea
  3. Department of Biomedical Engineering, Yonsei University, Wonju, Korea
  4. Department of Biomedical Engineering, Hanyang University, Seoul, Korea
  5. School of Electronic and Electrical Engineering, Sungkyunwkan University, Suwon, 440-746, Korea
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Imaging and Radiology
  Diagnostic Radiology
  Interventional Radiology
  Neuroradiology
  Ultrasound
  Internal Medicine
  
• 出版者：Springer Berlin / Heidelberg
• ISSN：1432-1084

文摘

Objectives The aim of our study was to determine the diagnostic value of a novel image analysis method called parametric response mapping (PRM) for prediction of intrahepatic recurrence of hepatocellular carcinoma (HCC) treated with conventional transcatheter arterial chemoembolization (TACE).